Tokyo Tape
Sign in
← Waqoo

Annual report

4937.TEDINET S100UZCZ
Period2023-10-01 → 2024-09-30
Filed2024-12-20
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 122
MetricValuePeriodScopeSource row
Revenue¥1.9bn2023-10-01 → 2024-09-30Cons.Net sales
Revenue¥1.7bn2022-10-01 → 2023-09-30Cons.Net sales
Revenue¥2.7bn2021-10-01 → 2022-09-30dCons.Net sales (5-year summary)
Operating income¥56m2023-10-01 → 2024-09-30Cons.Operating income
Operating income¥278m2022-10-01 → 2023-09-30Cons.Operating income
Ordinary income¥57m2023-10-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥288m2022-10-01 → 2023-09-30Cons.Ordinary income
Ordinary income−¥22m2021-10-01 → 2022-09-30dCons.Ordinary income loss (5-year summary)
Profit before tax¥57m2023-10-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥34m2022-10-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)−¥17m2023-10-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥28m2022-10-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥57m2021-10-01 → 2022-09-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income−¥17m2023-10-01 → 2024-09-30Cons.Profit loss
Net income¥28m2022-10-01 → 2023-09-30Cons.Profit loss
Total assets¥3.1bnat 2024-09-30Cons.Assets
Total assets¥1.6bnat 2023-09-30Cons.Assets
Total assets¥1.6bnat 2022-09-30dCons.Total assets (5-year summary)
Total liabilities¥993mat 2024-09-30Cons.Liabilities
Total liabilities¥809mat 2023-09-30Cons.Liabilities
Net assets / equity¥2.1bnat 2024-09-30Cons.Net assets
Net assets / equity¥773mat 2023-09-30Cons.Net assets
Net assets / equity¥743mat 2022-09-30dCons.Net assets
Cash and deposits¥1.5bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥1.3bnat 2023-09-30Cons.Cash and deposits
Cash & equivalents¥1.5bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.3bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥906mat 2022-09-30dCons.Cash and cash equivalents
Operating cash flow¥49m2023-10-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥456m2022-10-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥169m2021-10-01 → 2022-09-30dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥76m2023-10-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥49m2022-10-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥176m2021-10-01 → 2022-09-30dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow¥112m2023-10-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥8m2022-10-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥129m2021-10-01 → 2022-09-30dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥-5.032023-10-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥9.432022-10-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-19.042021-10-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥9.322022-10-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
Net assets per share¥590.33at 2024-09-30Cons.Net assets per share (5-year summary)
Net assets per share¥256.73at 2023-09-30Cons.Net assets per share (5-year summary)
Net assets per share¥246.98at 2022-09-30dCons.Net assets per share (5-year summary)
Equity ratio68.2%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio48.9%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio47.5%at 2022-09-30dCons.Equity to asset ratio (5-year summary)
ROE3.7%2022-10-01 → 2023-09-30Cons.Rate of return on equity (5-year summary)
Employees86at 2024-09-30Cons.Number of employees
Employees50at 2023-09-30Cons.Number of employees
Employees44at 2022-09-30dCons.Number of employees
Revenue¥1.6bn2023-10-01 → 2024-09-30StandaloneNet sales
Revenue¥1.7bn2022-10-01 → 2023-09-30StandaloneNet sales
Revenue¥2.7bn2021-10-01 → 2022-09-30dStandaloneNet sales (5-year summary)
Revenue¥4.7bn2020-10-01 → 2021-09-30dStandaloneNet sales (5-year summary)
Revenue¥4.5bn2019-10-01 → 2020-09-30dStandaloneNet sales (5-year summary)
Operating income−¥54m2023-10-01 → 2024-09-30StandaloneOperating income
Operating income¥252m2022-10-01 → 2023-09-30StandaloneOperating income
Ordinary income−¥28m2023-10-01 → 2024-09-30StandaloneOrdinary income
Ordinary income¥275m2022-10-01 → 2023-09-30StandaloneOrdinary income
Ordinary income−¥21m2021-10-01 → 2022-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥141m2020-10-01 → 2021-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥109m2019-10-01 → 2020-09-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥28m2023-10-01 → 2024-09-30StandaloneIncome before income taxes
Profit before tax¥34m2022-10-01 → 2023-09-30StandaloneIncome before income taxes
Net income−¥30m2023-10-01 → 2024-09-30StandaloneProfit loss
Net income¥32m2022-10-01 → 2023-09-30StandaloneProfit loss
Net income−¥57m2021-10-01 → 2022-09-30dStandaloneNet income loss (5-year summary)
Net income¥116m2020-10-01 → 2021-09-30dStandaloneNet income loss (5-year summary)
Net income¥99m2019-10-01 → 2020-09-30dStandaloneNet income loss (5-year summary)
Total assets¥2.9bnat 2024-09-30StandaloneAssets
Total assets¥1.6bnat 2023-09-30StandaloneAssets
Total assets¥1.6bnat 2022-09-30dStandaloneTotal assets (5-year summary)
Total assets¥1.9bnat 2021-09-30dStandaloneTotal assets (5-year summary)
Total assets¥1.2bnat 2020-09-30dStandaloneTotal assets (5-year summary)
Total liabilities¥810mat 2024-09-30StandaloneLiabilities
Total liabilities¥802mat 2023-09-30StandaloneLiabilities
Net assets / equity¥2.1bnat 2024-09-30StandaloneNet assets
Net assets / equity¥777mat 2023-09-30StandaloneNet assets
Net assets / equity¥743mat 2022-09-30dStandaloneNet assets
Net assets / equity¥801mat 2021-09-30dStandaloneNet assets (5-year summary)
Net assets / equity¥161mat 2020-09-30dStandaloneNet assets (5-year summary)
Cash and deposits¥1.2bnat 2024-09-30StandaloneCash and deposits
Cash and deposits¥1.2bnat 2023-09-30StandaloneCash and deposits
Cash & equivalents¥1.0bnat 2021-09-30dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥474mat 2020-09-30dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥128m2020-10-01 → 2021-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥88m2019-10-01 → 2020-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥6m2020-10-01 → 2021-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥2m2019-10-01 → 2020-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥703m2020-10-01 → 2021-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥16m2019-10-01 → 2020-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-8.772023-10-01 → 2024-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥10.572022-10-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-18.952021-10-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥41.612020-10-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥36.452019-10-01 → 2020-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥10.442022-10-01 → 2023-09-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥40.92020-10-01 → 2021-09-30dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥587.77at 2024-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥257.96at 2023-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥247.07at 2022-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥266.72at 2021-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥59.61at 2020-09-30dStandaloneNet assets per share (5-year summary)
Equity ratio72.3%at 2024-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio49.2%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio47.5%at 2022-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio42.1%at 2021-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio13.7%at 2020-09-30dStandaloneEquity to asset ratio (5-year summary)
ROE4.2%2022-10-01 → 2023-09-30StandaloneRate of return on equity (5-year summary)
ROE24.1%2020-10-01 → 2021-09-30dStandaloneRate of return on equity (5-year summary)
ROE88.1%2019-10-01 → 2020-09-30dStandaloneRate of return on equity (5-year summary)
Shares issued3,618,928at 2024-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued3,010,278at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued3,006,178at 2022-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued3,001,178at 2021-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,353,175at 2020-09-30dStandaloneTotal number of issued shares (5-year summary)
Employees60at 2024-09-30StandaloneNumber of employees
Employees50at 2023-09-30StandaloneNumber of employees
Employees44at 2022-09-30dStandaloneNumber of employees
Employees72at 2021-09-30dStandaloneNumber of employees
Employees59at 2020-09-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 39
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2023-10-01 → 2024-09-30¥322,000
Reconciling Itemsreconcilingdepreciation2023-10-01 → 2024-09-30¥745,000
Reconciling Itemsreconcilingrevenue2023-10-01 → 2024-09-30−¥2m
Reconciling Itemsreconcilingrevenue intersegment2023-10-01 → 2024-09-30−¥2m
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2024-09-30−¥393m
Direct To Consumer Businessreportable segmentdepreciation2023-10-01 → 2024-09-30¥5m
Direct To Consumer Businessreportable segmentrevenue2023-10-01 → 2024-09-30¥1.3bn
Direct To Consumer Businessreportable segmentrevenue external2023-10-01 → 2024-09-30¥1.3bn
Direct To Consumer Businessreportable segmentrevenue intersegment2023-10-01 → 2024-09-30¥75,000
Direct To Consumer Businessreportable segmentsegment profit2023-10-01 → 2024-09-30¥386m
Medical Supportreportable segmentcapex2023-10-01 → 2024-09-30¥80m
Medical Supportreportable segmentdepreciation2023-10-01 → 2024-09-30¥8m
Medical Supportreportable segmentrevenue2023-10-01 → 2024-09-30¥629m
Medical Supportreportable segmentrevenue external2023-10-01 → 2024-09-30¥627m
Medical Supportreportable segmentrevenue intersegment2023-10-01 → 2024-09-30¥2m
Medical Supportreportable segmentsegment profit2023-10-01 → 2024-09-30¥64m
—segment totalcapex2023-10-01 → 2024-09-30¥80m
—segment totaldepreciation2023-10-01 → 2024-09-30¥12m
—segment totalrevenue2023-10-01 → 2024-09-30¥1.9bn
—segment totalrevenue external2023-10-01 → 2024-09-30¥1.9bn
—segment totalrevenue intersegment2023-10-01 → 2024-09-30¥2m
—segment totalsegment profit2023-10-01 → 2024-09-30¥450m
Reconciling Itemsreconcilingdepreciation2022-10-01 → 2023-09-30¥777,000
Reconciling Itemsreconcilingrevenue2022-10-01 → 2023-09-30−¥1m
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2023-09-30−¥1m
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-09-30−¥353m
Direct To Consumer Businessreportable segmentdepreciation2022-10-01 → 2023-09-30¥5m
Direct To Consumer Businessreportable segmentrevenue2022-10-01 → 2023-09-30¥1.6bn
Direct To Consumer Businessreportable segmentrevenue external2022-10-01 → 2023-09-30¥1.6bn
Direct To Consumer Businessreportable segmentrevenue intersegment2022-10-01 → 2023-09-30¥1m
Direct To Consumer Businessreportable segmentsegment profit2022-10-01 → 2023-09-30¥679m
Medical Supportreportable segmentrevenue2022-10-01 → 2023-09-30¥167m
Medical Supportreportable segmentrevenue external2022-10-01 → 2023-09-30¥167m
Medical Supportreportable segmentsegment profit2022-10-01 → 2023-09-30−¥48m
—segment totaldepreciation2022-10-01 → 2023-09-30¥5m
—segment totalrevenue2022-10-01 → 2023-09-30¥1.7bn
—segment totalrevenue external2022-10-01 → 2023-09-30¥1.7bn
—segment totalrevenue intersegment2022-10-01 → 2023-09-30¥1m
—segment totalsegment profit2022-10-01 → 2023-09-30¥631m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,242
ItemContextValueUnit
Effect of exchange rate change on cash and cash equivalentsPrior1YearDuration－JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYearDuration－JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration398800000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration85246000JPY
Cash and cash equivalentsPrior2YearInstant906224000JPY
Cash and cash equivalentsPrior1YearInstant1305025000JPY
Increase in cash and cash equivalents resulting from share exchanges cfPrior1YearDuration－JPY
Increase in cash and cash equivalents resulting from share exchanges cfCurrentYearDuration115059000JPY
Cash and cash equivalentsPrior1YearInstant1305025000JPY
Cash and cash equivalentsCurrentYearInstant1505331000JPY
Number of consolidated subsidiariesCurrentYearInstant2
Cost of sales notes regarding write downs of inventoriesPrior1YearDuration-22668000JPY
Cost of sales notes regarding write downs of inventoriesCurrentYearDuration-15979000JPY
Payrolls and allowances etc sgaPrior1YearDuration233242000JPY
Payrolls and allowances etc sgaCurrentYearDuration326894000JPY
Advertising expenses sgaPrior1YearDuration94134000JPY
Advertising expenses sgaCurrentYearDuration246989000JPY
Freightage and packing expenses sgaPrior1YearDuration223172000JPY
Freightage and packing expenses sgaCurrentYearDuration181623000JPY
Amortization of goodwill sgaPrior1YearDuration－JPY
Amortization of goodwill sgaCurrentYearDuration91787000JPY
Compensations sgaPrior1YearDuration119822000JPY
Compensations sgaCurrentYearDuration214619000JPY
Sales commission sgaPrior1YearDuration116970000JPY
Sales commission sgaCurrentYearDuration90905000JPY
Depreciation sgaPrior1YearDuration6112000JPY
Depreciation sgaCurrentYearDuration8157000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodPrior1YearDuration－JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodCurrentYearDuration9169000JPY
Revenues from external customersPrior1YearDuration_jpcrp030000-asr_E36697-000DirectToConsumerBusinessReportableSegmentMember1559809000JPY
Revenues from external customersPrior1YearDuration_jpcrp030000-asr_E36697-000MedicalSupportReportableSegmentMember166504000JPY
Revenues from external customersPrior1YearDuration_ReportableSegmentsMember1726314000JPY
Revenues from external customersPrior1YearDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YearDuration1726314000JPY
Transactions with other segmentsPrior1YearDuration_jpcrp030000-asr_E36697-000DirectToConsumerBusinessReportableSegmentMember1233000JPY
Transactions with other segmentsPrior1YearDuration_jpcrp030000-asr_E36697-000MedicalSupportReportableSegmentMember－JPY
Transactions with other segmentsPrior1YearDuration_ReportableSegmentsMember1233000JPY
Transactions with other segmentsPrior1YearDuration_ReconcilingItemsMember-1233000JPY
Transactions with other segmentsPrior1YearDuration－JPY
Net salesPrior1YearDuration_jpcrp030000-asr_E36697-000DirectToConsumerBusinessReportableSegmentMember1561043000JPY
Net salesPrior1YearDuration_jpcrp030000-asr_E36697-000MedicalSupportReportableSegmentMember166504000JPY
Net salesPrior1YearDuration_ReportableSegmentsMember1727548000JPY
Net salesPrior1YearDuration_ReconcilingItemsMember-1233000JPY
Net salesPrior1YearDuration1726314000JPY
Operating incomePrior1YearDuration_jpcrp030000-asr_E36697-000DirectToConsumerBusinessReportableSegmentMember679347000JPY
Operating incomePrior1YearDuration_jpcrp030000-asr_E36697-000MedicalSupportReportableSegmentMember-48247000JPY
Operating incomePrior1YearDuration_ReportableSegmentsMember631100000JPY
Operating incomePrior1YearDuration_ReconcilingItemsMember-353158000JPY
Operating incomePrior1YearDuration277942000JPY
Depreciation segment informationPrior1YearDuration_jpcrp030000-asr_E36697-000DirectToConsumerBusinessReportableSegmentMember5335000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2023-09-30pass rounding
balance sheet identityconsolidated 2024-09-30pass
balance sheet identitynon_consolidated 2023-09-30pass
balance sheet identitynon_consolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · net assetsnon_consolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2023-10-01/2024-09-30pass
statement vs summary · revenueconsolidated 2022-10-01/2023-09-30pass
statement vs summary · revenueconsolidated 2023-10-01/2024-09-30pass
statement vs summary · revenuenon_consolidated 2022-10-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2023-10-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2023-09-30pass
statement vs summary · total assetsconsolidated 2024-09-30pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass
statement vs summary · total assetsnon_consolidated 2024-09-30pass